Site director Roland Jurke told the Northumberland Gazette earlier this month that: “It is not anticipated that the Alnwick site will form part of Sanofi Aventis' future research and development site network.”
Although Sanofi has yet to comment on the speculation, a recent article in French newspaper Le Figaro suggested that a potential Alnwick sale could be part of the reorganisation plans that the firm announced on June 30.
Around 170 people are currenctly employed by Sanofi at the facility in a variety of research and development (R&D) roles.